ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

34,277Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 2888

$2.04M Total Retail Price of All Prescriptions

Rank: 25 out of 2888

795 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 795 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

21% of this provider’s 795 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 27,805 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 1,653 1,483 1 1
SIMVASTATIN 1,238 1,054 2 2
DONEPEZIL HCL 1,039 999 3 26
FUROSEMIDE 930 797 4 6
NAMENDA 855 799 5 34
AMLODIPINE BESYLATE 819 712 6 5
LISINOPRIL 814 663 7 3
HYDROCODONE-ACETAMINOPHEN 754 605 S3 8 4
CITALOPRAM HBR 712 641 9 24
RISPERIDONE 698 500 10 72
METOPROLOL TARTRATE 687 610 11 10
HYDROCHLOROTHIAZIDE 593 453 12 15
OMEPRAZOLE 580 470 13 7
WARFARIN SODIUM 574 454 14 22
GABAPENTIN 541 438 15 13
LANTUS 445 308 16 45
METFORMIN HCL 413 332 17 8
NOVOLOG 403 295 18 114
FAMOTIDINE 399 355 19 75
POTASSIUM CHLORIDE 387 307 20 14
ESCITALOPRAM OXALATE 381 302 21 62
TRAZODONE HCL 378 314 22 43
TRAMADOL HCL 368 259 23 16
ALBUTEROL SULFATE 368 292 23 134
MIRTAZAPINE 364 325 25 54
ATORVASTATIN CALCIUM 359 277 26 9
QUETIAPINE FUMARATE 321 214 27 66
CARVEDILOL 297 238 28 21
METOPROLOL SUCCINATE 296 255 29 11
DIVALPROEX SODIUM 274 137 30 100
ZOLPIDEM TARTRATE 272 209 31 17
SERTRALINE HCL 269 209 32 27
KLOR-CON M20 268 183 33 90
CLOPIDOGREL 257 233 34 30
TAMSULOSIN HCL 257 206 34 29
EXELON 249 199 36 106
JANTOVEN 242 233 37 163
ALLOPURINOL 241 183 38 37
CLONIDINE HCL 229 173 39 39
ALENDRONATE SODIUM 216 216 40 23
DIGOXIN 211 181 41 55
PANTOPRAZOLE SODIUM 204 158 42 33
LIDODERM 193 147 43 105
LOSARTAN POTASSIUM 181 178 44 18
KLOR-CON M10 181 155 44 118
BUSPIRONE HCL 179 163 46 148
PLAVIX 175 154 47 40
CYMBALTA 175 107 47 44
DIOVAN 171 131 49 35
LEVETIRACETAM 160 117 50 103
CRESTOR 155 128 51 20
CARBIDOPA-LEVODOPA 153 143 52 113
NEXIUM 151 110 53 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 147 125 54 88
SEROQUEL 146 102 55 143
RAMIPRIL 145 107 56 73
NOVOLIN R 145 140 56 109
PRAVASTATIN SODIUM 144 102 58 12
PREDNISONE 141 120 59 42
METFORMIN HCL ER 140 92 60 53
LYRICA 140 125 60 69
TRAVATAN Z 140 120 60 239
PROMETHAZINE HCL 139 94 R 63 96
ATENOLOL 135 99 64 25
BENZTROPINE MESYLATE 135 74 R 64 191
DETROL LA 131 117 66 192
IPRATROPIUM BROMIDE 129 84 67 188
LEXAPRO 128 106 68 198
POLYETHYLENE GLYCOL 3350 122 112 69 93
OXYBUTYNIN CHLORIDE ER 122 95 69 132
SPIRONOLACTONE 121 100 71 70
RIVASTIGMINE 119 118 72 335
FLUOXETINE HCL 116 82 73 83
HYDRALAZINE HCL 114 101 74 59
ISOSORBIDE MONONITRATE ER 112 104 75 51
DIVALPROEX SODIUM ER 110 49 76 185
AMIODARONE HCL 109 88 77 167
LEVOFLOXACIN 108 93 78 57
PAROXETINE HCL 103 63 79 84
PHENYTOIN 99 54 80 302
LOVASTATIN 97 96 81 41
GLIMEPIRIDE 96 73 82 36
VALPROIC ACID 95 67 83 278
HALOPERIDOL 94 70 84 282
RANITIDINE HCL 93 88 85 56
PHENYTOIN SODIUM EXTENDED 92 57 86 128
MELOXICAM 87 70 87 31
FINASTERIDE 82 64 88 102
HUMALOG 81 38 89 166
SUCRALFATE 81 66 89 187
GLIPIZIDE 81 79 89 50
LATANOPROST 79 59 92 197
NITROGLYCERIN PATCH 79 49 92 183
ADVAIR DISKUS 78 53 94 60
CYCLOBENZAPRINE HCL 78 43 R 94 68
TRIAMCINOLONE ACETONIDE 77 57 96 145
ROPINIROLE HCL 76 61 97 115
BACLOFEN 76 23 97 121
NYSTATIN 75 62 99 178
AZITHROMYCIN 74 60 100 38
MEGESTROL ACETATE 73 70 R 101 140
METOCLOPRAMIDE HCL 71 43 102 116
FENOFIBRATE 71 56 102 65
VENLAFAXINE HCL ER 70 32 104 120
PRAMIPEXOLE DIHYDROCHLORIDE 70 46 104 202
LAMOTRIGINE 69 39 106 257
TOPIRAMATE 68 31 107 206
LIPITOR 65 45 108 78
ENALAPRIL MALEATE 64 50 109 49
CIPROFLOXACIN HCL 63 55 110 47
DILTIAZEM ER 59 59 111 182
ENABLEX 58 57 112 269
SANTYL 58 36 112 210
FLUTICASONE PROPIONATE 58 50 112 32
RESTASIS 56 45 115 352
PREMARIN 56 47 R 115 129
TERAZOSIN HCL 56 52 115 152
TRICOR 55 55 118 91
FLUDROCORTISONE ACETATE 55 55 118 377
GALANTAMINE HBR 53 53 120 325
HYDROXYZINE HCL 53 37 R 120 174
LEVEMIR 53 49 120 135
LACTULOSE 52 36 123 111
CLOBETASOL PROPIONATE 51 50 124 298
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.